inspect molecule / ammonia n-13
Ammonia N-13
Ammonia N-13 o--o \/ /\ o--o
Ammonia N-13 is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.
active moietyAmmonia N-13
administration routeIntravenous
price comparison status2 snapshots
safety signal rating54 / 100
Radioactive Diagnostic Agent [EPC]openFDA NDC seedopenFDA NDC37.5 mCi/mL
price index
Typical Class Estimates
⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Radioactive Diagnostic Agent [EPC].
$24.50USvsCA$14.20CA
- US Typical Class Average · US$24.50
30 tablets · acquisition-reference · Molecule Index Class Benchmark ↗
- CA Typical Class Average · CACA$14.20
30 tablets · formulary-benefit-price · Molecule Index Class Benchmark ↗
Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.
query trend --id 2420 --12m
Price Trend Index
Deterministic trailing 12-month value delta index for this active ingredient class.
Rising Fast3M: +2.6%12M: +0.4%
Jul 2025Jun 2026
Jan 2026$23.84
Feb 2026$23.60
Mar 2026$23.50
Apr 2026$23.45
May 2026$23.73
Jun 2026$24.11
01 / chemistryBrigham and Women's Hospital, Inc., The
Ingredient Breakdown
active moietyAmmonia N-13
formulationIntravenous Radioactive Diagnostic Agent [EPC]
mechanism of action
Radioactive Diagnostic Agent [EPC]
available strengths
37.5 mCi/mL
02 / ingredientsexcipients
Excipients / Maker Notes
- Not enriched yet from label source.
Manufacturer Notes
- This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals
Steps To Take Safely
- Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
- Read the official label for route-specific directions, contraindications, and storage.
- Ask a clinician or pharmacist before substituting products across countries or formulations.
- Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.
Side-Effect Signals
- label-specific reactions
- allergic reaction
- interaction risk
- dose/formulation confusion
- urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.
$ grep ingredient --same